3',6'-Dihydroxy-2',4',5',7'-tetraiodo-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one

Catalog No. :
ACWPTJ975
CAS No. :
15905-32-5
Molecular Formula :
C20H8I4O5
Molecular Weight :
835.90

IUPAC Name:3',6'-dihydroxy-2',4',5',7'-tetraiodo-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one

3',6'-Dihydroxy-2',4',5',7'-tetraiodo-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$70.00Login to see priceInquiryInquiry
25g95%$152.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3',6'-Dihydroxy-2',4',5',7'-tetraiodo-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one
IUPAC Name3',6'-dihydroxy-2',4',5',7'-tetraiodo-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one
MDL No.MFCD00005044
Molecular FormulaC20H8I4O5
Molecular Weight835.90
SMILESO=C1OC2(C=3C=CC=CC13)C4=CC(I)=C(O)C(I)=C4OC5=C(I)C(O)=C(I)C=C52
InChI KeyOALHHIHQOFIMEF-UHFFFAOYSA-N
SynonymErythrosin B | Tetraiodofluorescein | 15905-32-5 | Iodeosin | Solvent Red 140 | Erythrosine acid | ERYTHROSINE | Erythrosine, phenolic | 2',4',5',7'-Tetraiodofluorescein | 2,4,5,7-Erythrosin | E127 | C.I. Solvent Red 140 | 3',6'-dihydroxy-2',4',5',7'-tetraiodospiro[2-benzofuran-
CAS No.15905-32-5
PubChem CID3259

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACWPTJ975 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWPTJ975 route product structure diagram
    ACWPTJ97515905-32-5
Inquiry

2. ACWPTJ975 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWPTJ975 route product structure diagram
    ACWPTJ97515905-32-5
Inquiry

Comments (0)